Mechanistically, SNHG16 has an oncogenic role in regulating CRC cell proliferation via the SNHG16/miR-214-3p/ABCB1 axis, indicating novel potential biomarkers and therapeutic targets for CRC. Here, SNHG16 is linked to colorectal carcinoma.